AW
REGN icon

Alpha Windward’s Regeneron Pharmaceuticals REGN Stock Holding History

Alpha Windward’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-454
Closed -$126K – 442
2019
Q3 		$126K Buy
454
+18
+4% +$5.33K 0.09% 278
2019
Q2 		$133K Buy
436
+17
+4% +$5.66K 0.09% 287
2019
Q1 		$172K Hold
419
– – 0.11% 264
2018
Q4 		$156K Sell
419
-68
-14% -$24.9K 0.11% 252
2018
Q3 		$197K Buy
487
+3
+0.6% +$1.14K 0.12% 266
2018
Q2 		$167K Buy
484
+50
+12% +$15.6K 0.1% 277
2018
Q1 		$149K Buy
434
+45
+12% +$15.7K 0.09% 288
2017
Q4 		$146K Buy
389
+8
+2% +$3.24K 0.09% 287
2017
Q3 		$170K Sell
381
-3
-0.8% -$1.43K 0.1% 273
2017
Q2 		$189K Buy
384
+1
+0.3% +$438 0.12% 274
2017
Q1 		$148K Buy
383
+16
+4% +$5.93K 0.1% 284
2016
Q4 		$135K Buy
367
+41
+13% +$15.6K 0.09% 282
2016
Q3 		$131K Buy
326
+34
+12% +$13.6K 0.09% 286
2016
Q2 		$102K Sell
292
-118
-29% -$45.4K 0.07% 286
2016
Q1 		$148K Buy
410
+25
+6% +$10.3K 0.11% 269
2015
Q4 		$209K Buy
385
+7
+2% +$3.79K 0.15% 225
2015
Q3 		$176K Buy
378
+212
+128% +$114K 0.13% 254
2015
Q2 		$85K Sell
166
-31
-16% -$15.1K 0.06% 289
2015
Q1 		$89K Hold
197
– – 0.06% 293
2014
Q4 		$81K Sell
197
-36
-15% -$14.2K 0.05% 293
2014
Q3 		$84K Hold
233
– – 0.06% 284
2014
Q2 		$66K Sell
233
-17
-7% -$5.04K 0.04% 284
2014
Q1 		$75K Hold
250
– – 0.05% 284
2013
Q4 		$69K Buy
250
+1
+0.4% +$288 0.05% 289
2013
Q3 		$78K Hold
249
– – 0.06% 283
2013
Q2 		$56K Buy
+249
New +$58K 0.04% 291

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Alpha Windward's REGN Position: Q4 2019 in Review

Alpha Windward sold out of Regeneron Pharmaceuticals (REGN) in Q4 2019, closing a stake of 454 shares — an estimated $126K sold.

Alpha Windward first reported a position in REGN in Q2 2013 and held it in 26 quarters. The position peaked at $209K in Q4 2015. 703 funds tracked by Wall St. Rank hold REGN as of Q4 2019.

  • Alpha Windward reported no remaining Regeneron Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Alpha Windward sold 454 Regeneron Pharmaceuticals shares in Q4 2019, an estimated $126K.
  • Alpha Windward first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 26 quarters.
  • Alpha Windward's Regeneron Pharmaceuticals position peaked at $209K in Q4 2015.
  • 703 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2019.

Based on Alpha Windward's 13F filing for Q4 2019, filed 14 Jan 2020.